TABLE 1.
MICs of agents against anaerobes
Organisma | Drug(s) | MIC (μg/ml)
|
||
---|---|---|---|---|
Range | 50% | 90% | ||
Bacteroides fragilis (69/70) | Doripenem | 0.125-8 | 0.25 | 1 |
Imipenem | 0.03-2 | 0.125 | 0.25 | |
Meropenem | 0.06-8 | 0.125 | 1 | |
Ertapenem | 0.125-8 | 0.25 | 2 | |
Piperacillin-tazobactam | ≤0.125-8 | 0.5 | 1 | |
Amoxicillin-clavulanate | 0.25-4 | 0.5 | 2 | |
Ceftriaxone | ≤0.125->128 | 64 | >128 | |
Clindamycin | 0.125->16 | 1 | 4 | |
Metronidazole | 0.25-2 | 1 | 1 | |
Bacteroides thetaiotaomicron (30/30) | Doripenem | 0.25-0.5 | 0.25 | 0.5 |
Imipenem | 0.25-0.5 | 0.25 | 0.5 | |
Meropenem | 0.125-0.5 | 0.25 | 0.5 | |
Ertapenem | 0.5-2 | 0.5 | 1 | |
Piperacillin-tazobactam | 2-32 | 16 | 16 | |
Amoxicillin-clavulanate | 0.5-8 | 1 | 1 | |
Ceftriaxone | 64->128 | >128 | >128 | |
Clindamycin | 0.25->16 | 4 | 8 | |
Metronidazole | 0.25-2 | 1 | 1 | |
Bacteroides ovatus (10/10) | Doripenem | 0.25-4 | 0.25 | 1 |
Imipenem | 0.125-2 | 0.25 | 0.5 | |
Meropenem | 0.25-4 | 0.25 | 0.5 | |
Ertapenem | 0.5-8 | 0.5 | 2 | |
Piperacillin-tazobactam | 4-16 | 4 | 8 | |
Amoxicillin-clavulanate | 0.5-8 | 0.5 | 2 | |
Ceftriaxone | 64->128 | 64 | >128 | |
Clindamycin | 2->16 | 2 | >16 | |
Metronidazole | 0.5-2 | 1 | 2 | |
Bacteroides vulgatus (20/20) | Doripenem | 0.125-1 | 0.25 | 1 |
Imipenem | 0.06-1 | 0.5 | 1 | |
Meropenem | 0.125-1 | 0.25 | 1 | |
Ertapenem | 0.06-2 | 0.125 | 2 | |
Piperacillin-tazobactam | 0.5-64 | 8 | 16 | |
Amoxicillin-clavulanate | 0.5-8 | 0.5 | 8 | |
Ceftriaxone | 2->128 | 16 | >128 | |
Clindamycin | ≤0.016->16 | 0.03 | 0.5 | |
Metronidazole | ≤0.125-1 | 0.5 | 1 | |
Bacteroides distasonis (8/20) | Doripenem | 0.25-1 | 0.5 | 1 |
Imipenem | 0.25-1 | 0.5 | 1 | |
Meropenem | 0.125-1 | 0.125 | 0.5 | |
Ertapenem | 0.5-2 | 0.5 | 1 | |
Piperacillin-tazobactam | 4-8 | 4 | 8 | |
Amoxicillin-clavulanate | 1-8 | 2 | 8 | |
Ceftriaxone | 1->128 | 8 | >128 | |
Clindamycin | 0.03->16 | 4 | >16 | |
Metronidazole | 1-2 | 1 | 1 | |
Prevotella bivia (21/30) | Doripenem | 0.06-0.25 | 0.06 | 0.125 |
Imipenem | ≤0.016-0.125 | 0.03 | 0.06 | |
Meropenem | 0.03-0.25 | 0.06 | 0.125 | |
Ertapenem | 0.06-0.5 | 0.25 | 0.25 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-4 | 0.25 | 4 | |
Ceftriaxone | ≤0.125-128 | 8 | 64 | |
Clindamycin | ≤0.016->16 | 0.03 | >16 | |
Metronidazole | 0.5-4 | 2 | 2 | |
Prevotella disiens (7/10) | Doripenem | 0.03-0.125 | 0.06 | 0.125 |
Imipenem | 0.03-0.125 | 0.03 | 0.125 | |
Meropenem | 0.03-0.125 | 0.03 | 0.125 | |
Ertapenem | 0.03-0.25 | 0.06 | 0.25 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-2 | ≤0.125 | 0.5 | |
Ceftriaxone | ≤0.125-64 | 2 | 64 | |
Clindamycin | ≤0.016->16 | ≤0.016 | 0.03 | |
Metronidazole | 0.5-2 | 0.5 | 2 | |
Prevotella intermedia/Prevotella nigrescens (19/30) | Doripenem | ≤0.016-0.125 | 0.03 | 0.06 |
Imipenem | ≤0.016-0.06 | 0.03 | 0.03 | |
Meropenem | ≤0.016-0.125 | 0.03 | 0.06 | |
Ertapenem | ≤0.016-0.125 | 0.03 | 0.06 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-1 | ≤0.125 | 0.5 | |
Ceftriaxone | ≤0.125-64 | 4 | 16 | |
Clindamycin | ≤0.016->16 | ≤0.016 | ≤0.016 | |
Metronidazole | 0.25-1 | 0.5 | 1 | |
Prevotella melaninogenica/Prevotella denticola (16/20) | Doripenem | ≤0.016-0.25 | 0.03 | 0.125 |
Imipenem | ≤0.016-0.125 | 0.03 | 0.06 | |
Meropenem | ≤0.016-0.25 | 0.06 | 0.25 | |
Ertapenem | 0.03-0.5 | 0.125 | 0.5 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-4 | 0.25 | 2 | |
Ceftriaxone | ≤0.125-128 | 4 | 64 | |
Clindamycin | ≤0.016->16 | 0.03 | 0.03 | |
Metronidazole | ≤0.125-1 | 0.5 | 1 | |
Prevotella corporis (6/10) | Doripenem | 0.03-0.06 | 0.03 | 0.06 |
Imipenem | ≤0.016-0.06 | 0.03 | 0.06 | |
Meropenem | ≤0.016-0.06 | 0.03 | 0.06 | |
Ertapenem | ≤0.016-0.125 | 0.03 | 0.06 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-0.5 | ≤0.125 | 0.25 | |
Ceftriaxone | ≤0.125-32 | 4 | 32 | |
Clindamycin | ≤0.016-1 | ≤0.016 | 0.03 | |
Metronidazole | 0.25-1 | 0.5 | 1 | |
Prevotella buccae (3/10) | Doripenem | 0.06-0.125 | 0.06 | 0.125 |
Imipenem | 0.03-0.06 | 0.03 | 0.03 | |
Meropenem | 0.06-0.06 | 0.06 | 0.06 | |
Ertapenem | 0.06-0.125 | 0.125 | 0.125 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-2 | ≤0.125 | 1 | |
Ceftriaxone | ≤0.125-64 | 0.25 | 4 | |
Clindamycin | ≤0.016-0.03 | ≤0.016 | 0.03 | |
Metronidazole | 0.5-2 | 1 | 1 | |
Porphyromonas asaccharolytica (0/4) | Doripenem | ≤0.016-0.03 | ||
Imipenem | ≤0.016-0.03 | |||
Meropenem | ≤0.016 | |||
Ertapenem | ≤0.016 | |||
Piperacillin-tazobactam | ≤0.125 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | ≤0.125 | |||
Clindamycin | ≤0.016 | |||
Metronidazole | ≤0.125-0.25 | |||
Porphyromonas gingivalis (0/3) | Doripenem | ≤0.016 | ||
Imipenem | ≤0.016 | |||
Meropenem | ≤0.016 | |||
Ertapenem | ≤0.016 | |||
Piperacillin-tazobactam | ≤0.125 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | ≤0.125 | |||
Clindamycin | ≤0.016 | |||
Metronidazole | ≤0.125 | |||
Porphyromonas levii (0/1) | Doripenem | 0.03 | ||
Imipenem | ≤0.016 | |||
Meropenem | ≤0.016 | |||
Ertapenem | ≤0.016 | |||
Piperacillin-tazobactam | ≤0.125 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | ≤0.125 | |||
Clindamycin | ≤0.016 | |||
Metronidazole | ≤0.125 | |||
Fusobacterium nucleatum (2/20) | Doripenem | ≤0.016-0.03 | ≤0.016 | 0.03 |
Imipenem | ≤0.016-0.06 | 0.03 | 0.03 | |
Meropenem | ≤0.016-0.06 | ≤0.016 | 0.03 | |
Ertapenem | ≤0.016-0.06 | ≤0.016 | 0.03 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-0.5 | ≤0.125 | ≤0.125 | |
Ceftriaxone | ≤0.125-0.5 | 0.25 | 0.5 | |
Clindamycin | 0.03-0.125 | 0.06 | 0.125 | |
Metronidazole | ≤0.125-0.5 | ≤0.125 | ≤0.125 | |
Fusobacterium necrophorum (0/18) | Doripenem | ≤0.016-0.25 | ≤0.016 | 0.25 |
Imipenem | ≤0.016-0.25 | ≤0.016 | 0.25 | |
Meropenem | ≤0.016-0.125 | ≤0.016 | 0.125 | |
Ertapenem | ≤0.016-0.125 | ≤0.016 | 0.125 | |
Piperacillin-tazobactam | ≤0.125-0.5 | ≤0.125 | 0.5 | |
Amoxicillin-clavulanate | ≤0.125-0.5 | ≤0.125 | 0.25 | |
Ceftriaxone | ≤0.125 | ≤0.125 | ≤0.125 | |
Clindamycin | 0.03-0.125 | 0.06 | 0.125 | |
Metronidazole | ≤0.125-0.5 | ≤0.125 | 0.5 | |
Fusobacterium varium (0/10) | Doripenem | 0.06-1 | 0.125 | 0.25 |
Imipenem | 0.5-2 | 1 | 1 | |
Meropenem | 0.06-0.25 | 0.125 | 0.25 | |
Ertapenem | 0.06-0.125 | 0.06 | 0.125 | |
Piperacillin-tazobactam | 2-32 | 8 | 8 | |
Amoxicillin-clavulanate | 1-4 | 2 | 4 | |
Ceftriaxone | ≤0.125-8 | 4 | 8 | |
Clindamycin | 2->16 | 4 | 16 | |
Metronidazole | ≤0.125-0.5 | 0.25 | 0.5 | |
Fusobacterium mortiferum (2/10) | Doripenem | 0.125-1 | 0.25 | 1 |
Imipenem | 0.25-1 | 1 | 1 | |
Meropenem | 0.06-1 | 0.125 | 0.5 | |
Ertapenem | 0.06-0.5 | 0.06 | 0.5 | |
Piperacillin-tazobactam | ≤0.125-4 | 0.25 | 2 | |
Amoxicillin-clavulanate | 0.5-32 | 1 | 16 | |
Ceftriaxone | ≤0.125->128 | 128 | ≥128 | |
Clindamycin | 0.06-8 | 0.06 | 0.25 | |
Metronidazole | ≤0.125 | ≤0.125 | ≤0.125 | |
Finegoldia magna (0/10) | Doripenem | 0.06-0.125 | 0.06 | 0.125 |
Imipenem | 0.03-0.06 | 0.06 | 0.06 | |
Meropenem | 0.06-0.125 | 0.06 | 0.125 | |
Ertapenem | 0.03-0.06 | 0.06 | 0.06 | |
Piperacillin-tazobactam | ≤0.125-0.25 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-0.5 | 0.25 | 0.25 | |
Ceftriaxone | 1-8 | 8 | 8 | |
Clindamycin | 0.125->16 | 2 | >16 | |
Metronidazole | 0.25-1 | 0.5 | 1 | |
Micromonas micros (0/10) | Doripenem | ≤0.016-0.125 | ≤0.016 | 0.06 |
Imipenem | 0.03-0.125 | 0.03 | 0.06 | |
Meropenem | 0.03-0.25 | 0.03 | 0.25 | |
Ertapenem | ≤0.016-0.25 | 0.03 | 0.125 | |
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125-1 | ≤0.125 | 0.5 | |
Ceftriaxone | ≤0.125-2 | ≤0.125 | 1 | |
Clindamycin | 0.125-0.5 | 0.25 | 0.5 | |
Metronidazole | ≤0.125-0.5 | 0.25 | 0.5 | |
Peptostreptococcus anaerobius (0/10) | Doripenem | 0.125-2 | 0.25 | 2 |
Imipenem | 0.06-2 | 0.06 | 1 | |
Meropenem | 0.25-2 | 0.25 | 2 | |
Ertapenem | 0.25-2 | 0.5 | 2 | |
Piperacillin-tazobactam | 0.25-16 | 0.25 | 16 | |
Amoxicillin-clavulanate | 0.25-32 | 0.5 | 32 | |
Ceftriaxone | 0.5-16 | 0.5 | 16 | |
Clindamycin | 0.03-0.5 | 0.03 | 0.25 | |
Metronidazole | ≤0.125-1 | 0.5 | 1 | |
Anaerococcus prevotii (0/4) | Doripenem | 0.03 | ||
Imipenem | ≤0.016-0.03 | |||
Meropenem | ≤0.016-0.03 | |||
Ertapenem | ≤0.016-0.125 | |||
Piperacillin-tazobactam | ≤0.125 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | ≤0.125-0.5 | |||
Clindamycin | 0.125-0.5 | |||
Metronidazole | 0.25-2 | |||
Anaerococcus tetradius (0/6) | Doripenem | ≤0.016-0.06 | 0.03 | |
Imipenem | ≤0.016-0.03 | 0.03 | ||
Meropenem | 0.03-0.06 | 0.03 | ||
Ertapenem | 0.06-0.125 | 0.06 | ||
Piperacillin-tazobactam | ≤0.125 | ≤0.125 | ||
Amoxicillin-clavulanate | ≤0.125 | ≤0.125 | ||
Ceftriaxone | 0.25-0.5 | 0.25 | ||
Clindamycin | 0.5-1 | 0.5 | ||
Metronidazole | 1-4 | 2 | ||
Peptoniphilus asaccharolyticus (0/10) | Doripenem | ≤0.016-0.125 | ≤0.016 | 0.03 |
Imipenem | ≤0.016-0.06 | ≤0.016 | 0.03 | |
Meropenem | ≤0.016-0.125 | ≤0.016 | 0.03 | |
Ertapenem | ≤0.016-0.5 | ≤0.016 | 0.06 | |
Piperacillin-tazobactam | ≤0.125-0.25 | ≤0.125 | ≤0.125 | |
Amoxicillin-clavulanate | ≤0.125 | ≤0.125 | ≤0.125 | |
Ceftriaxone | ≤0.125-1 | ≤0.125 | 1 | |
Clindamycin | 0.06->16 | 0.06 | >16 | |
Metronidazole | ≤0.125-2 | 1 | 1 | |
Clostridium perfringens (0/30) | Doripenem | ≤0.016-0.06 | 0.03 | 0.03 |
Imipenem | ≤0.016-0.125 | 0.06 | 0.125 | |
Meropenem | ≤0.016-0.03 | ≤0.016 | ≤0.016 | |
Ertapenem | ≤0.016-0.125 | 0.06 | 0.125 | |
Piperacillin-tazobactam | ≤0.125-1 | 0.25 | 0.5 | |
Amoxicillin-clavulanate | ≤0.125 | ≤0.125 | ≤0.125 | |
Ceftriaxone | ≤0.125-4 | 2 | 4 | |
Clindamycin | 0.06-4 | 1 | 2 | |
Metronidazole | 0.5-2 | 1 | 2 | |
Clostridium difficile (0/20) | Doripenem | 1-4 | 2 | 4 |
Imipenem | 4-8 | 8 | 8 | |
Meropenem | 1-4 | 2 | 4 | |
Ertapenem | 4-8 | 4 | 8 | |
Piperacillin-tazobactam | 8-32 | 16 | 32 | |
Amoxicillin-clavulanate | 1-2 | 1 | 2 | |
Ceftriaxone | 32-128 | 64 | 64 | |
Clindamycin | 4->16 | 8 | >16 | |
Metronidazole | 0.25-1 | 0.5 | 0.5 | |
Clostridium innocuum (0/6) | Doripenem | 1 | 1 | |
Imipenem | 1-2 | 1 | ||
Meropenem | 1-2 | 2 | ||
Ertapenem | 2-4 | 2 | ||
Piperacillin-tazobactam | 1-2 | 1 | ||
Amoxicillin-clavulanate | 0.25-0.5 | 0.5 | ||
Ceftriaxone | 8-16 | 16 | ||
Clindamycin | 0.5-2 | 1 | ||
Metronidazole | 0.5-1 | 1 | ||
Clostridium ramosum (0/5) | Doripenem | 0.5-1 | 0.5 | |
Imipenem | 0.25-0.5 | 0.25 | ||
Meropenem | 0.5-2 | 1 | ||
Ertapenem | 1-2 | 1 | ||
Piperacillin-tazobactam | ≤0.125-0.25 | 0.25 | ||
Amoxicillin-clavulanate | ≤0.125 | ≤0.125 | ||
Ceftriaxone | 0.25-0.5 | 0.5 | ||
Clindamycin | 2-8 | 4 | ||
Metronidazole | 0.5-2 | 2 | ||
Clostridium bifermentans (0/4) | Doripenem | 0.06-0.125 | ||
Imipenem | 0.25-0.5 | |||
Meropenem | 0.125 | |||
Ertapenem | 0.125 | |||
Piperacillin-tazobactam | 0.5-1 | |||
Amoxicillin-clavulanate | 0.25-2 | |||
Ceftriaxone | 0.25 | |||
Clindamycin | 0.06-0.25 | |||
Metronidazole | 0.25-0.5 | |||
Clostridium clostridioforme (0/2) | Doripenem | 1 | ||
Imipenem | 2 | |||
Meropenem | 1 | |||
Ertapenem | 1-2 | |||
Piperacillin-tazobactam | 16 | |||
Amoxicillin-clavulanate | 1 | |||
Ceftriaxone | 64 | |||
Clindamycin | 0.06 | |||
Metronidazole | ≤0.125-0.25 | |||
Clostridium sordellii (0/2) | Doripenem | 0.03 | ||
Imipenem | 0.125 | |||
Meropenem | 0.06 | |||
Ertapenem | 0.03 | |||
Piperacillin-tazobactam | 0.25 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | ≤0.125-0.25 | |||
Clindamycin | 1 | |||
Metronidazole | 0.5-1 | |||
Clostridium paraputrificum (0/1) | Doripenem | 0.25 | ||
Imipenem | 0.5 | |||
Meropenem | 0.25 | |||
Ertapenem | 0.125 | |||
Piperacillin-tazobactam | 0.25 | |||
Amoxicillin-clavulanate | 0.5 | |||
Ceftriaxone | 4 | |||
Clindamycin | 8 | |||
Metronidazole | 0.5 | |||
Clostridium cadaveris (0/1) | Doripenem | 0.03 | ||
Imipenem | 0.125 | |||
Meropenem | 0.03 | |||
Ertapenem | ≤0.016 | |||
Piperacillin-tazobactam | 0.5 | |||
Amoxicillin-clavulanate | ≤0.125 | |||
Ceftriaxone | 4 | |||
Clindamycin | 0.03 | |||
Metronidazole | 0.25 |
The numbers of β-lactamase-positive strains/numbers of strains tested are indicated in parentheses.